Not currently recruiting at University of California Health
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Summary
- Eligibility
- for people ages 2-17 (full criteria)
- Location
- at UCSD
- Dates
- study startedcompletion around
- Principal Investigator
- by Jennifer Sharon Graves, MD, PhD (ucsd)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Jennifer Sharon Graves, MD, PhD (ucsd)
Professor Of Clinical, Neurosciences, Vc-health Sciences-schools. Authored (or co-authored) 85 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Horizon Therapeutics Ireland DAC
- ID
- NCT05549258
- Phase
- Phase 2 Neuromyelitis Optica Spectrum Disorders Research Study
- Study Type
- Interventional
- Participants
- Expecting 15 study participants
- Last Updated